The Mixed Phenotype of Asthma and COPD: the Overlap Syndrome
The Mixed Phenotype of Asthma and COPD: the Overlap Syndrome: A Comparison of Asthma Outcomes in Smoking vs Non-smoking Patients With an Incomplete Reversibility of Airway Obstruction (IRAO)
RATIONALE:
In asthmatic subjects, smoking can lead to several changes in disease characterictics. in smokers of more than 20 pack-years, chronic obstructive pulmonary disease (COPD) can be associated with asthma, also called asthma-COPD overlap syndrome (ACOS). Increasing data support the concept that ACOS is a clinical entity. However, this should be further studied in order to better target therapy.
AIM:
The objective of this study is to evaluate the comparative features of ACOS
METHODS:
This will be a descriptive study comparing the features of the ACOS with the features of asthmatic subjects with an incomplete reversibility of airway obstruction (IRAO).The study will be done over 1 or 2 visits (within a week interval), according to subjects' availability. The visit will include completion of different questionnaires (asthma control asthma quality of life, medical history, exacerbations, etc.), a thoracic examination, allergy skin-prick tests, spirometry and bronchodilator response, lung volumes and compliance measurements, exhaled nitric oxide measurement, blood sampling and a sputum induction.
연구 개요
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
-
Quebec, 캐나다, G1V 4G5
- Institut Universitaire de cardiologie et de pneumologie de Quebec
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
ALL SUBJECTS
- Subjects aged 45 years and older.
- Free of any other respiratory condition, except for asthma and/or COPD, which may interfere with the tests.
- Asthma that requires a baseline treatment with inhaled corticosteroids and/or additional asthma medication.
- Free of respiratory infection in the 4 weeks preceding the study.
- No changes in the asthma and COPD-related medications in the 4 weeks preceding the study.
- If female, not pregnant (or lactating).
- Able to adhere to study procedures.
- Able and willing to provide written informed consent to participate in the study, in accordance with international conference on harmonization (ICH) good clinical practice (GCP) requirements.
ACOS SUBJECTS
1. Smokers or ex-smokers of at least 20 pack-years. 2. With an IRAO (see definitions section). IRAO SUBJECTS
- Long-life non-smokers or ex-smokers defined as someone who smoked less than 5 pack-years and who completely stopped smoking for at least 12 months before inclusion in the study.
- With an IRAO.
Exclusion Criteria:
ALL SUBJECTS
- With COPD without a past diagnosis of asthma.
- Unstable respiratory or non-respiratory condition.
- Any active chronic inflammatory disease.
- Any evidence of malignancy (active and/or treated) within the previous 5 years.
- Any significant concomitant illness or injury that would interfere with the subject's participation in the study.
- Any history of bronchial thermoplasty. IRAO SUBJECTS
- Use of any nicotine containing product within 1 year prior to study entry or a smoking history of > 5 pack-years.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
코호트 및 개입
그룹/코호트 |
|---|
|
ACOS smoking history >20 pack-years
Subjects with asthma-COPD overlap syndrome
|
|
IRAO smoking history <5 pack-years
Subjects with an incomplete reversibility of airway obstruction
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Total asthma control questionnaire (ACQ) score
기간: Baseline
|
Measurement of asthma control using a 0-6 scale.
The questionnaire includes 6 questions.
Total score is the mean of the scores from all questions.
Total score ranges from 0 to 6.
A lower score is better.
|
Baseline
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Spirometry results
기간: Baseline
|
Forced expiratory volume in one second (FEV1), forced vital capacity (FVC), FEV1/FVC
|
Baseline
|
|
Sputum eosinophil percentage
기간: Baseline
|
Percentage of sputum eosinophils
|
Baseline
|
|
Concentration of Blood biomarkers
기간: Baseline
|
alpha 1 antitrypsine, C-reactive protein (CRP), fibrinogen
|
Baseline
|
|
Asthma quality of life questionnaire (AQLQ) score
기간: Baseline
|
Measurement of asthma quality of life using the Mini asthma quality of life questionnaire.
It is a 7-point scale questionnaire (where 1 is greatest impairment and 7 is least impairment) containing 15 uqestions divided into 4 domains : symptoms (5 items), activity limitation (4 items), emotional function (3 items), and exposure to environmental stimuli (3 items).
during the last 2 weeks.
The overall score is the mean of all the responses.
Each domain score is calculated from the mean of the items that relate to it.
|
Baseline
|
|
Number of patients with comorbidities
기간: Baseline
|
gastro-oesophageal reflux disease (GERD), obstructive sleep apnea (OSA), anxiety, depression
|
Baseline
|
|
Number of asthma exacerbations in the previous year
기간: Baseline
|
emergency room (ER) visits, hospitalizations, oral corticosteroids treatment, unscheduled medical visits
|
Baseline
|
|
Change from baseline total Asthma Control Questionnaire (ACQ) score at one-year follow-up
기간: Baseline to one-year follow-up
|
Measurement of asthma control using a 0-6 scale.
The questionnaire includes 6 questions.
Total score is the mean of the scores from all questions.
Total score ranges from 0 to 6.
A lower score is better.
|
Baseline to one-year follow-up
|
|
Change from baseline number of exacerbations at one-year follow-up
기간: Baseline to one-year follow-up
|
emergency room (ER) visits, hospitalizations, oral corticosteroids treatment, unscheduled medical visits
|
Baseline to one-year follow-up
|
공동 작업자 및 조사자
스폰서
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .